© 2020 MJH Life Sciences™ and Psychiatric Times. All rights reserved.
CME
Between Stoned and a Hard Place? Navigating Cannabis Medicolegal Issues
October 20, 2020
Given the significant variation in medical cannabis laws amongst states and the continually shifting legal landscape regarding its use, medical cannabis presents a unique challenge for medical professionals who consider recommending it to their patients
Tackling Psychoneuroendocrinology May Lead to Better Treatment and Outcomes
October 19, 2020
New and improved treatment options are surfacing, thanks to an improved understanding of psychoneuroendocrinology.
Should Benzodiazepines and Opioids Be Used Concurrently?
October 19, 2020
While there are risks for prescribing benzodiazepines and opioids concurrently, experts agree there are times when it may be an appropriate treatment decision.
The Debate Goes On: Are Antidepressants for Bipolar Moot?
October 18, 2020
Psychiatric Disorders and Migraine Comorbidity: Treatment Implications
October 16, 2020
Clinicians have a limited repertoire when it comes to a dual approach to migraine and psychiatric treatment. Read more about Dr Moawad's presentation at the Annual Psychiatric Times® World CME Conference™.
A Glimpse Into the Future of Psychiatry: Educator of the Year Award
October 16, 2020
“The best indicator of the future is looking at the past,” Sidney Zisook, MD, told attendees of the Annual Psychiatric Times® World CME Conference™. Dr Zisook spoke to the future of psychiatry in the Educator of the Year Lecture.